Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ICU | US
-0.11
-3.02%
Healthcare
Biotechnology
30/06/2024
02/06/2026
3.53
3.60
3.73
3.52
SeaStar Medical Holding Corporation a medical device company develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver Colorado.
View LessLow Debt to Equity (< 0.25)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
42.4%1 month
71.1%3 months
118.9%6 months
108.9%-
-
-
-0.46
0.91
-8.13
-
-
-
14.80M
14.80M
-
-
-
-
-
3.59
5.29
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.79
Range1M
1.64
Range3M
3.03
Rel. volume
0.78
Price X volume
213.81K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| iBio Inc | IBIO | Biotechnology | 1.76 | 16.08M | -6.88% | n/a | 20.92% |
| NeuroSense Therapeutics Ltd. Ordinary Shares | NRSN | Biotechnology | 0.8 | 15.85M | -1.57% | n/a | -2.11% |
| VistaGen Therapeutics Inc | VTGN | Biotechnology | 0.58 | 15.69M | -10.42% | n/a | 1.90% |
| Zivo Bioscience Inc | ZIVO | Biotechnology | 4.45 | 15.40M | n/a | -25.20% | |
| Adial Pharmaceuticals Inc | ADIL | Biotechnology | 2.36 | 15.12M | -3.67% | n/a | 0.00% |
| 22nd Century Group Inc | XXII | Biotechnology | 0.48 | 15.09M | -17.24% | n/a | -1072.15% |
| CytoMed Therapeutics Limited Ordinary Shares | GDTC | Biotechnology | 1.14 | 13.16M | -0.10% | n/a | 3.98% |
| Kezar Life Sciences Inc | KZR | Biotechnology | 0.18 | 13.13M | 5.88% | n/a | 11.69% |
| Kala Pharmaceuticals Inc | KALA | Biotechnology | 2.39 | 13.10M | 8.64% | n/a | 268.29% |
| PLUR | PLUR | Biotechnology | 2.365 | 12.94M | -1.87% | n/a | 30845.83% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.11 | 16.22M | -2.63% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4275 | 8.26M | -0.47% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.71 | 4.37M | 1.18% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0063 | 580.95K | 12.50% | n/a | -37.05% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4821 | 265.64K | -11.54% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -8.13 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 118.92 | - | Riskier |
| Debt to Equity | -0.46 | -1.23 | Expensive |
| Debt to Assets | 0.91 | 0.25 | Expensive |
| Market Cap | 14.80M | - | Emerging |